NIH-funded research R21 grant

Investigating how aging cells affect severe COVID-19 in patients with obesity and liver disease

Official title: The role of senescence in severe COVID-19

Funded at University of Pennsylvania · NIH-11129638 · Data updated 2026-11-12

This study is looking at how aging cells in the liver might make COVID-19 worse for people with obesity and liver disease, and it hopes to find out if getting rid of these cells can help improve their symptoms.

More COVID-19 research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 2, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$203,125
NIH project number5R21AI183111-02
Project IDNIH-11129638 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with obesity or non-alcoholic steatohepatitis (NASH) who have experienced severe COVID-19 symptoms.

Less likely to help

Patients without obesity or liver disease, or those who have not experienced severe COVID-19 symptoms, may not benefit from this research.

What this research studies

This research explores the connection between aging cells and severe COVID-19 outcomes in patients with obesity and non-alcoholic steatohepatitis (NASH). The team will create organoids from liver tissues of NASH patients to study how these senescent cells contribute to the body's inflammatory response during COVID-19. By using mouse models and human-derived cells, they aim to determine if removing these aging cells can improve severe symptoms related to COVID-19. This approach may provide insights into new treatment strategies for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that alleviate severe COVID-19 symptoms in patients with obesity and liver disease.

How similar studies have gone: Other research has indicated that targeting senescent cells can improve outcomes in various diseases, suggesting potential success for this novel approach.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Raabe, Tobias D. — University of Pennsylvania
  • Study coordinator: Raabe, Tobias D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.